SMO Overview

SCRI’s Site Management Organization (SMO) offers operational, regulatory and other centralized research support services for sites on industry-sponsored and investigator-initiated trials. With access to a broad patient base, the SMO conducts and supports phase I through III and outcomes-based trials throughout its network of sites.

The SMO offers support services for trials across tumor types including complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers.

Centralized Support Services:

  • Menu management & accelerated start up
  • Regulatory
  • Budget, contract, and financial services
  • Protocol operations
  • Global quality & education
  • Technology integration & support
  • Financial planning & analysis

Our Differentiators:

  • Rapid study activation timelines
  • Community clinic-based model at SCRI sites provides access to larger numbers of patients
  • Efficiencies with budget, contract, and informed consent
  • Utilization of central IRBs
  • Standardized SOPs and quality metrics across all SCRI sites
  • Partners with the Personalized Medicine team to rapidly identify patients for trials

Learn more about SCRI at scri.com